Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-700-1 | CAS number: 70616-89-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1983
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- gene for histidine synthesis
- Species / strain / cell type:
- other: S. typhimurium TA 1535, TA 97, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 supernatant of rat liver and a mixture of cofactors
- Test concentrations with justification for top dose:
- 10, 100, 500, 1000, 2500 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle used: water
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- other: 4-nitro-1,2-phenylenediamine (CAS: 99-56-9); 2-aminofluorene (CAS: 153-78-6); 2-aminoanthracene (CAS: 613-13-8)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)NUMBER OF REPLICATIONS: 3PREPARATION OF S9 METABOLIC ACTIVATORThe metabolic activation was performed by S9 fraction of rat liver homogenate and mixture of cofactors. The liver homogenate was prepared from Wistar male rats, previously induced with Delor 106 (mixture of PCBs). Cofactors (NADP and glucoso-6-phosphate) were dissolved in buffer. Each plate in all experiments with metabolic activation contained 0.5 mL of buffer with NADP and glucoso-6-phosphate and 20 µL S9. In experiments without metabolic activation only buffer was added to the top agar.DETERMINATION OF CYTOTOXICITY- Any supplementary information relevant to cytotoxicity: no cytotoxicity observed
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Based on results of this test, it is obvious that test substance, Reactive Orange 13, shouldn´t be considered as a mutagen for all the Salmonella typhimurium with as well as without metabolic activation.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- None
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only four tester strains tested; no tester strain to detect cross-linking mutagens was included
- Principles of method if other than guideline:
- None
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- None
- Target gene:
- Histidine for Salmonella
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- Strain and type of MutationS. typhimurium TA 100 base-pair substitutionS. typhimurium TA 1535 base-pair substitutionS. typhimurium TA 98 frame-shiftS. typhimurium TA 1537 frame-shift
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat-liver post mitochondrial supernatant (S9 fraction)
- Test concentrations with justification for top dose:
- 61.7 to 5000.0 µg/plate
- Vehicle / solvent:
- Bidistilled water
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- With metabolic activation for strains TA 100, TA 98 and TA 1537
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- With metabolic activation for strain TA 1535
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- Without metabolic activation for strains TA 100 and TA 1535
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- Without metabolic activation for strain TA 98
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Without metabolic activation for strain TA 1537
- Details on test system and experimental conditions:
- Preliminary range finding testA range finding test was carried out with strain TA 100 with and without metabolic activation at six concentrations of the test substance and one negative control according to a Standard Operating Procedure of Genetic Toxicology. The highest concentration applied was 5000 ug/plate. The five lower concentrations decreased by a factor of three. The plates were inverted and incubated for about 48 hours at 37±1.5°C in darkness. Thereafter, they were evaluated by counting the colonies and determining the background lawn. One plate per test substance concentration and negative control was used.Mutagenicity testThe mutagenicity test was performed with the Salmonella typhimurium strains TA 98, TA 100,TA 1535, TA 1537 with and without metabolic activation according to Standard Operating Procedures of Genetic Toxicology. Each of the five concentrations of the test substance, a negative and a positive control were tested, using three plates per test substance concentration and controls. The highest concentration applied was determined in the preliminary range finding test and the four lower concentrations decreased by a factor of three. The plates were inverted and incubated for about 48 hours at 37±1.5°C in darkness. Thereafter, they were evaluated by counting the number of colonies and determining the background lawn.
- Rationale for test conditions:
- None
- Evaluation criteria:
- The test substance will be considered to be positive in the test system if the following condition is met:At least a reproducible meaningful increase of the mean number of revertants per plate above that of the negative control at any concentration for one or more of the strains tested.Generally a concentration-related effect should be demonstrable.
- Statistics:
- None
- Key result
- Species / strain:
- other: S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- None
- Conclusions:
- FAT 40170/D did not led to an increase in the incidence of histidine-prototrophic mutants by comparison with the negative controls.
- Executive summary:
The study was performed to investigate the potential of FAT 40170 to induce gene mutations according to the plate incorporation test using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100. The following strains of Salmonella typhimurium were used: TA 98, TA 100, TA 1535 and TA 1537. The test was performed with and without the addition of rat-liver post mitochondrial supernatant (S9 fraction) as an extrinsic metabolic activation system. The compound was dissolved in bidistilled water and tested at five concentrations in the range of 61.7 to 5000.0 ug/plate in the presence and absence of a metabolic activation system. In order to confirm the results, the experiments were repeated with and without metabolic activation at the same concentrations. Each strain was additionally tested in the presence and in the absence of a metabolic activation system with a suitable, known mutagen as positive control. In both experiments, performed with and without metabolic activation, none of the tested concentrations of FAT 40170/D led to an increase in the incidence of histidine-prototrophic mutants by comparison with the negative control.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- Adopted: July 28th, 2015
- Deviations:
- yes
- Remarks:
- see Any other information on materials and methods
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell transformation assay
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction of rat liver homogenate and mixture of cofactors
- Test concentrations with justification for top dose:
- 2.0, 1.0, 0.5 and 0.25 mg/mLOn the basis of cytotoxicity testing; these concentrations were non-toxic.
- Vehicle / solvent:
- DMEM (Dulbecco's minimal essential medium)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- same as negative control
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- CHEMICALS AND MEDIA - Solvent: DMEM (Dulbecco's minimal essential medium)- Positive controls: 7,12-dimethylbenz[a]anthracene (DMBA, CAS 57-97-6) Ethylmethane sulphonate (EMS, CAS 62-50-0)- Media: DMEM (Dulbecco's minimal essential medium) HAT (suplement, GibcoCleansing medium for reduction of mutants at the start of experiment) FBS (Sigma Fetal Bovine Serum, part of complete growth medium Trypsin-EDTA (For release of cells from the bottom of dishes) Atb: penicillin-streptomycin (For prevention of contamination, part of complete growth medium) Complete growth medium (DMEM + FBS + Atb - 500 : 55 : 5.5) - Selective agent: 6-thioguanine (CAS 154-24-7)- Dye for staining of colonies: methylene blue (CAS 122965-43-9)CELLS V79The lung fibroblasts V79 from male Chinese hamster were used for testing. Frozen permanent cell culture was obtained from European Collection of Cell Cultures (ECACC). The cells were kept at -196 ºC under liquid nitrogen. After activation, cells are grown in DMEM medium with L-glutamine and 10 % FBS in incubator (5 % CO2, 37±1°C, moistened). Cells underwent maximum 5 passages after thawing the original culture delivered from cell collection before using for testing. Cleansing of cultures was performed 5 days before treatment with complete medium supplemented with HAT supplement due to elimination of mutants. Cleansing was not performed in experiment without metabolic activation, because of bad growth of cells in HAT medium.MYCOPLASMA DETERMINATIONCell cultures were checked for mycoplasma contamination. At every experiment one withdrawal of media has been performed and sent to the contract laboratory performing mycoplasma determination.CONTROLSEach experiment included negative, solvent and positive controls. Solvent control = negative control plates contained 9.0 mL of complete medium and 1.0 mL of DMEM or the test substance diluted in DMEM. Positive control plates contained 9.9 or 9.95 mL of complete medium and 100 or 50 µL of relevant positive control substance diluted in DMSO. Positive control substance for experiments without metabolic activation: Ethylmethane sulphonate (CAS 62-50-0), 5 mM solution, 50 or 100 µL per plate; positive control substance for experiments with metabolic activation: 7,12-dimethylbenz[a]anthracene (CAS 57-97-6), 5 µg/mL – final concentration, 50 µL per plate METABOLIC ACTIVATION SYSTEMThe metabolic activation was performed by S9 fraction of rat liver homogenate and mixture of cofactors. The liver homogenate was prepared from Wistar male rats weighing approximately 200 g, previously induced with Delor 106 (a mixture of PCBs). Delor 106 was diluted with olive oil to a concentration of 200 mg/mL, and each rat was administered a single injection of 500 mg/kg 5 days before S9 preparation. The S9 was prepared according to the methods described by Maron and Ames. The liver was removed from each animal and washed in ice cold 0.15 M KCl. The livers washed were mixed with another 0.15 M KCl (3 mL/g wet liver) homogenized in a grinder, and the tissue suspension was centrifuged for 10 min at 9000 g. Aliquots of the supernatant (S9) were stored in plastic tubes using sterile technique at a temperature below –70°C. Every lot of S9 was tested for sterility and activity in the Ames test with the aid of bacterial strain TA 98 according to internal SOP M/12. Activity was within expected limits. Cofactors (NADP and glucoso-6-phosphate) were dissolved in PBS. Composition of S9 mix was as follows:S9 mix composition: S9 tissue fraction: 1.0 mL NADP (0.1M): 0.4 mL glucose-6-phosphate (0.1M): 0.5 mL KC1 (0.33M): 1.0 mL MgCl2 (0.lM): 0.5 mL Phosphate Buffer (0.2 M): 4.6 mLEach plate in all experiments with metabolic activation contained 4.0 mL of S9mix, 5.0 mL of complete medium and 1.0 mL of the test substance solution in DMEM.
- Evaluation criteria:
- Each experiment is evaluated separately using modified two-fold increase rule according to Claxton L.D. et al, Mutat. Res.,189, 83-91, 1987 (2). The mutagenic potential is indicated by increasing number of mutants in treated groups in comparison to the negative solvent control (modified two-fold increase rule and any of the results outside the distribution of the historical negative control data) and/or by dependence of increasing number of mutants on dose (dose-response relationship).
- Statistics:
- Each experiment is evaluated separately using modified two-fold increase rule according to Claxton L.D. et al, Mutat. Res.,189, 83-91, 1987. The mutagenic potential is indicated by increasing number of mutants in treated groups in comparison to the negative solvent control (modified two-fold increase rule and any of the results outside the distribution of the historical negative control data) and/or by dependence of increasing number of mutants on dose (dose-response relationship).There is no requirement for verification of a clearly positive or negative response.In cases when the response is neither clearly negative nor clearly positive than a repeat experiment possibly using modified experimental conditions (e.g. concentration spacing, other metabolic activation conditions i.e. S9 concentration or S9 origin) could be performed.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Under the experimental design the test substance, Reactive Orange 13, was non-mutagenic for V79 cells with as well as without metabolic activation.
- Executive summary:
The test substance, Reactive Orange 13, was assayed for mutagenicity in the In Vitro Mammalian Cell Gene Mutation Test. The test was based on OECD Test Guideline No. 476 – In Vitro Mammalian Cell Gene Mutation Test (2015), which is analogous to the EU method B.17.
Chinese hamster V79 lung fibroblasts were used for testing.
The test substance was dissolved in DMEM. A cytotoxicity test without metabolic activation was performed in advance. Concentrations used were 0.1, 0.5, 1.0, 1.5 and 2.0 mg/mL.
On the basis of the result, five concentrations for the mutagenicity experiment without metabolic activation were tested in the range 0.25-2.0 mg/mL.
The same concentrations were used in the experiment with metabolic activation. No toxicity was observed in any concentration.
Under the experimental conditions indicated above, the test substance, Reactive Orange 13, was non-mutagenic for V79 cells with and without metabolic activation.
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Version / remarks:
- adopted 29th July, 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
- Species / strain / cell type:
- other: human peripheral blood lymphocytes
- Details on mammalian cell type (if applicable):
- CELLS USED- Source of cells: certified medical laboratory (MeDiLa)- Sex, age and number of blood donors if applicable: healthy non smoking females up to 35 years of age
- Additional strain / cell type characteristics:
- not applicable
- Cytokinesis block (if used):
- cytochalasin B
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction of rat liver homogenate and mixture of cofactors
- Test concentrations with justification for top dose:
- 125, 250, 500, 1000 and 2000 µg/mL
- Vehicle / solvent:
- Vehicle(s)/solvent(s) used: none
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- other: colchicine (CAS: 64-86-8)
- Details on test system and experimental conditions:
- CHEMICALS AND MEDIA Positive controls: - colchicine (CAS: 64-86-8)- cyclophosphamide monohydrate (CAS: 6055-19-2) Media:- RPMI 1640 with L-Glutamine (with Sodium Bicarbonate (NaHCO3) and Phenol Red (C19H13NaO5S) as a pH indicator)- foetal bovine serum- RPMI-M (RPMI 1640 + foetal bovine serum + penicilin-streptomycin + PHA-M) Other chemicals:- PHA-M (phytohaemagglutinin M, lectin extracted from red kidney beans)- penicilin-streptomycin- cytochalasin B- MgCl2 . 6H2O- NADP disodium salt- D-glucose-6-phosphate disodium salt- Dimethylsulfoxide - KCl- methanol- acetic acid- Giemsa-Romanowski- S9 metabolic activatorTEST SYSTEMThe human peripheral blood lymphocytes used for testing were obtained from healthy non-smoking females (up to 35 years of age). Peripheral blood (heparinized) is taken from donors in certified medical laboratory (MeDiLa) in the morning and transported into the test facility as soon as possible.SCHEDULE OF THE TEST - Day 1: Blood sampling. Blood was taken and then stored in the fridge until the next day.- Day 2 and 3: Cultivation. The whole human peripheral blood was transferred to the growth medium and mitogenic stimulator (phytohaemagglutinin M) was added. These operations were carried out in a laminar box at room temperature. The cultivation runs without interrupting for 48 hours (37°C ± 1°C; 5% CO2).- Day 4: Exposition. The test substance, positive and negative control substances were added to the individual cultures (in a laminar box at room temperature). In the first experiment without and with metabolic activation (S9-mix), the cultures were washed (after 3 hours of continuous exposure to the test substance in 37°C ± 1°C; 5% CO2) and transferred to fresh culture medium with cytokinesis blocker (cytochalasin B). Washing and transfer were carried out in a laminar box at room temperature. Then the lymphocytes were cultured (37°C ± 1°C; 5% CO2) for remaining period (total 23 hours from the start of exposure). - Day 5: Harvesting of cultures. All cultures were processed in a laminar box at room temperature, (with hypotonia, fixation solution). Suspensions were dropped on clear microspcopic slides. The slides were allowed to dry at least overnight. - Day 6: Staining of slides. Slides were stained by Giemsa-Romanowski staining solution.EXPERIMENTAL PROCEDURE Selection of concentrations: The test substance was suspended in culture medium. The starting suspension (2000 g/mL - according OECD TG 487 paragraph 31) was diluted and concentration series (2000, 1000, 500, 250 and 125 µg/mL) was prepared. The concentration series was prepared also according OECD TG 487 (concentration intervals of 2 to 3 fold). At first the cytotoxicity of test substance was determined by measuring of cell proliferation. For the highest concentration of the test substance used for analysis of genotoxic effect the cytotoxicity should not be higher than 55±5 %. Fresh solutions of the test substance were prepared before each experiment. In the highest prepared concentration (2000 µg/mL) the pH was measured. Controls: Each experiment included corresponding positive controls (known clastogen - cyclophosphamide; and known aneugen – colchicine) and negative controls (untreated culture; in case of experiment with metabolic activation system – untreated culture with S9 mix). The aneugenicity control (colchicine) serves also as the positive control without S9-mix, and the clastogenicity control (cyclophosphamide) is used to test of the adequacy of the metabolic activation system used. The final concentration of colchicine in cultures was 0.7 µg/mL (eventually 0.007 µg/mL at 23h exposure of the test substance) and the final concentration of cyclophosphamide in cultures is 7.8 µg/mL. Preparation and using of S9-mix:The metabolic activation was performed by S9 fraction of rat liver homogenate and mixture of cofactors. The liver homogenate was prepared from Wistar male rats weighing approximately 200 g, previously induced with Delor 106 (mixture of PCBs). Delor 106 was diluted with olive oil to a concentration of 200 mg/mL, and each rat was administered a single injection of 500 mg/kg 5 days before S9 preparation. The S9 was prepared according to the methods described by Maron and Ames (1983). The liver was removed from each animal and washed in ice cold 0.15 M KCl. The livers washed were mixed with another 0.15 M KCl (3 mL/g wet liver) homogenized in a grinder, and the tissue suspension was centrifuged for 10 min at 9000 g. Aliquots of the supernatant (S9) were stored in plastic tubes using sterile technique at a temperature below –70 C. Fresh solution of the cofactors (1.6 mM MgCl2.6H2O, 0.8 mM NADP and 1 mM glucose-6-phosphate) was prepared before each experiment with metabolic activation. Each culture in experiments with metabolic activation contained 18.5 µL of S9 and 18.5 µL of cofactors solution (S9-mix). Cell cycle length determination:The proliferation of lymphocytes was evaluated by doubling time experiment. Four separate tubes with blood in the medium were prepared in day 2. Every following day (day 3, day 4 and day 5) lymphocytes were isolated and quantified. Then the proliferation curve was constructed and cell cycle length was determined. The lymphocyte`s cell cycle length was 16 hours. This is suitable to experimental design described above according to OECD TG 487. The cell cycle length determination is done once per 6 months. Results of the experiment are archived in the laboratory.Treatment and cultivation:50 µL of an appropriate concentration of test substance solution in medium was added to lymphocyte culture (2.5 mL growth medium RPMI-M + cca 150-210 µL human peripheral blood) in the presence and absence of a metabolic activation system (S9-mix). Duplicate cultures were used for each concentration and control. It was carried out in a laminar box at room temperature. Cultures were treated with the test substance 48 hours after mitogenic stimulation. The cultivation runs without interrupting for 48 hours (37°C ± 1°C; 5% CO2) after mitogenic stimulation.In the first experiment without and with metabolic activation (S9-mix) the concentrations 125, 250, 500, 1000 and 2000 µg/mL were used. After shaking the cultures were cultivated with the test substance for 3 hours. After that they were rinsed up by RPMI-M and then transported to the fresh growth medium (RPMI-M) with 11.25 µL of cytochalasin B (the final concentration in cultures was 4.5 µg/mL). Cultures were then cultivated and sampled after 23 hours since the beginning of treatment.The first experiments gave negative results, so the second experiment without metabolic activation had to be done with extended exposure. In the second experiment (prolonged exposition without activation) the concentrations 250, 500, 1000 and 2000 µg/mL were used. Cultures were treated with test substance without metabolic activation for 23 hours in the presence of cytochalasin B (7.5 µL; final concentration in cultures was 3 µg/mL). No transport to fresh medium was needed in that experimental design.Preparation of slides:Cultures were harvested 23 hours after the beginning of treatment (after about 1.5 to 2 cell cycles). Cultures were treated by hypotonic solution (RT, ca 5 min.) and then they were centrifuged (1200 rpm, 10 min.). After removing of hypotonic solution, fixation solution was added to cultures and cultures were centrifuged again (1200 rpm, 10 min.). The addition of fixation solution and centrifugation were repeated three times. Suspensions were then dropped on clear microscopic slides. Preparations were let to dry at laboratory temperature and then slides were stained by Giemsa Romanowski staining solution.Scoring of cells for cytotoxicity and genotoxicity evaluation:All slides were coded before microscopic analysis. At least 1000 cells were scored per each concentration and controls divided equally between the duplicates for determination of cytotoxicity. CBPI index was calculated from ratio of mononucleated, binucleated and multinucleated cell at each culture. The cytotoxic effect was characterized as % of cytotoxicity. 2000 binucleated cells were analysed per each concentration and control divided equally between the duplicates for determination of genotoxicity. The genotoxic effect is characterized by numbers of binucleated cells with micronuclei.Concentrations evaluated in analysis of cytotoxicity:In the first experiment without and with metabolic activation (S9-mix) the concentrations 125, 250, 500, 1000 and 2000 µg/mL have been analysed for cytotoxic effect.In the second experiment (prolonged exposition without activation) the concentrations 250, 500, 1000 and 2000 µg/mL have been analysed for cytotoxic effect.Concentrations evaluated in analysis of genotoxic effect:For genotoxic effect analysis the concentrations with low or without cytotoxicity were used.In the first experiment without and with metabolic activation (S9-mix) the concentrations 500, 1000 and 2000 μg/mL were analysed. In the second experiment (prolonged exposition without activation) the concentrations 250, 500, 1000 and 2000 µg/mL were analysed.
- Evaluation criteria:
- see Any other information on materials and methods
- Key result
- Species / strain:
- other: human peripheral blood lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- not applicable
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Under the experimental conditions described above, the test substance, Reactive Orange 13, had no genotoxic effects in the human peripheral blood lymphocytes in experiments both without and with metabolic activation.
- Executive summary:
In Vitro Mammalian Cell Micronucleus Test assayed genotoxicity of the test substance, Reactive Orange 13. The test was performed according to OECD Test Guideline No. 487 - In Vitro Mammalian Cell Micronucleus Test, Adopted 29th July, 2016.
The human peripheral blood lymphocytes from healthy donors were used for testing. The test substance was suspended in RPMI medium and assayed in five concentrations 125 - 2000 µg/mL, which were applied to cultures in volume of 50 µL. Experiments were performed without as well as with metabolic activation with a supernatant of rat liver and a mixture of cofactors.
Under the experimental design described above, the test substance, Reactive Orange 13, had no genotoxic effects in the human peripheral blood lymphocytes in experiments both without and with metabolic activation.
The result of micronucleus test was negative, test substance is then considered not able to induce chromosome breaks and/or chromosome gain or loss in this test system.
Referenceopen allclose all
Table No. 1: Bacteria reverse mutation test results
Dose (µg/plate) | S9 (μL) | Rt/Rc | S9 (μL) | Rt/Rc | ||
Salmonella typhimurium TA 97 | ||||||
water | 0 | 1.0 | 1.0 | 20 | 1.0 | 1.0 |
10 | 0 | 1.1 | 1.0 | 20 | 1.1 | 1.0 |
100 | 0 | 1.0 | 1.0 | 20 | 0.9 | 1.0 |
500 | 0 | - | 0.9 | 20 | 1.0 | - |
1000 | 0 | 1.1 | 0.9 | 20 | 1.0 | 1.0 |
2500 | 0 | 1.1 | 0.9 | 20 | 0.9 | 1.0 |
5000 | 0 | 0.9 | - | 20 | - | 0.9 |
NPD | 0 | 7.7 | 6.0 | 20 | 16.3 | 12.8 |
2-AF | 0 | - | - | 20 | - | - |
Salmonella typhimurium TA 98 | ||||||
water | 0 | 1.0 | 1.0 | 20 | 1.0 | 1.0 |
10 | 0 | 0.8 | 1.0 | 20 | 1.1 | 1.2 |
100 | 0 | 0.9 | 1.1 | 20 | 0.9 | 1.1 |
500 | 0 | - | 1.0 | 20 | - | 1.3 |
1000 | 0 | 1.1 | 1.0 | 20 | 0.8 | 1.5 |
2500 | 0 | 0.9 | 1.0 | 20 | 0.9 | 1.1 |
5000 | 0 | 0.7 | - | 20 | 0.7 | - |
NPD | 0 | 56.2 | 106.6 | - | - | - |
2-AF | - | - | - | 20 | 101.2 | 92.9 |
Salmonella typhimurium TA 100 | ||||||
water | 0 | 1.0 | 1.0 | 20 | 1.0 | 1.0 |
10 | 0 | 1.0 | 0.9 | 20 | 1.0 | 0.9 |
100 | 0 | 1.1 | 0.9 | 20 | 0.9 | 1.0 |
1000 | 0 | 1.0 | 1.0 | 20 | 1.0 | 1.1 |
2500 | 0 | 1.1 | 1.0 | 20 | 1.0 | 1.1 |
5000 | 0 | 1.1 | 1.0 | 20 | 1.0 | 1.0 |
AS | 0 | 8.2 | 6.5 | - | - | - |
2-AF | - | - | - | 20 | 14.4 | 16.1 |
Salmonella typhimurium TA 1535 | ||||||
water | 0 | 1.0 | 1.0 | 20 | 1.0 | 1.0 |
10 | 0 | 1.0 | 1.3 | 20 | 1.1 | 1.0 |
100 | 0 | 1.2 | 1.0 | 20 | 1.0 | 0.9 |
500 | 0 | - | 1.2 | - | - | - |
1000 | 0 | 0.7 | 0.9 | 20 | 0.9 | 0.8 |
2500 | 0 | 0.6 | 0.8 | 20 | 1.0 | 0.7 |
5000 | 0 | 0.8 | 0.5 | 20 | 0.9 | 0.6 |
AS | 0 | 51.8 | 52.0 | - | - | - |
2-AA | - | - | - | 20 | 17.0 | 13.2 |
AS sodium azide
NPD 4-nitro-1,2-phenylenediamine
2-AF 2-aminofluorene
2-AA 2-aminoanthracene
None
Table 1:Summary of results: 3-hour treatment with and without metabolic activation
Conc. (mg/mL) | MF/105 | Mt/Msc | |
with metabolic activation | |||
NC | 1.28 | 1.00 | |
0.25 | 1.29 | 1.01 | |
0.50 | 0.90 | 0.71 | |
1.00 | 1.17 | 0.91 | |
2.00 | 1.09 | 0.85 | |
DMBA | 27.67 | 21.62 | |
without metabolic activation | |||
NC | 1.22 | 1.00 | |
0.25 | 0.88 | 0.72 | |
0.50 | 1.20 | 0.98 | |
1.00 | 1.07 | 0.87 | |
2.00 | 0.86 | 0.71 | |
EMS50 | 23.95 | 19.61 | |
EMS100 | 49.79 | 40.77 |
MF – mutation frequencies
NC – negative control
Mt/Msc – number of mutants in test concentration vs number of mutants in solvent control
DMBA – 7,12-dimethylbenz[a]anthracene
EMS50 –ethylmethane sulphonate, 50 µL
EMS100 – ethylmethane sulphonate, 100 µL
Table No. 1: Evaluation ofgenotoxicity
Treatment/Test substance concentration | Number of binucleated cells with MN | Number of MN | Average number of BN cells with MN per 1000 binucleated cells | Average number of MN per 1000 binucleated cells | Mt/Mc | ||||
3h exposure, without metabolic activation | |||||||||
UTC | 15 | 16 | 7.5 | 8 | 1.00 | ||||
2000mg/mL | 12 | 12 | 6 | 6 | 0.80 | ||||
1000mg/mL | 11 | 13 | 5.5 | 6.5 | 0.73 | ||||
500mg/mL | 12 | 12 | 6 | 6 | 0.80 | ||||
colchicine | 89 | 118 | 44.5 | 59 | 5.93 | ||||
3h exposure, with metabolic activation | |||||||||
S9-mix (positive control) | 13 | 13 | 6.5 | 6.5 | 1.00 | ||||
2000 mg/mL + S9-mix | 12 | 16 | 6 | 8 | 0.92 | ||||
1000mg/mL + S9-mix | 20 | 23 | 10 | 11.5 | 1.54 | ||||
500mg/mL + S9-mix | 14 | 15 | 7 | 7.5 | 1.08 | ||||
UTC | 15 | 16 | 7.5 | 8 | 1.15 | ||||
cyclophosphamide + S9-mix | 64 | 66 | 32 | 33 | 4.92 | ||||
23h exposure, without metabolic activation | |||||||||
UTC | 38 | 42 | 19 | 21 | 1.00 | ||||
2000mg/mL | 41 | 45 | 20.5 | 22.5 | 1.08 | ||||
1000mg/mL | 38 | 39 | 19 | 19.5 | 1.00 | ||||
500mg/mL | 39 | 41 | 19.5 | 20.5 | 1.03 | ||||
250mg/mL | 41 | 43 | 20.5 | 21.5 | 1.08 | ||||
colchicine | 76 | 83 | 38 | 41.5 | 2.00 |
Mt/Mc ratio of number of binucleated cells with micronuclei at tested dose to number of binucleated cells with micronuclei in negative control
UTC untreated culture
S9 amount of supernatant of rat liver homogenate per plate
MN mononucleated cells
BN binucleated cells
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
In vitro studies did not revealed any mutagenic effect, so that the test substance need not be classified as mutagenic according to Regulation (EC) No. 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.